Fatty Liver Diseases
VIDEO: Mental health, other complications associated with obesity
In this video, Jamy D. Ard, MD, FTOS, discusses the complications of obesity and the impact on patients.
VIDEO: ‘What you can do now’ for patients with MASLD
PHILADELPHIA — In this video, Nancy S. Reau, MD, FAASLD, AGAF, provides an overview of her postgraduate course presentation at the ACG Annual Scientific Meeting.
VIDEO: TERN-501 ‘could be a best-in-class molecule’ alone, as combination therapy for MASH
BOSTON — Treatment with TERN-501, a selective thyroid hormone receptor beta agonist, reduced liver fat content and fibro-inflammation among patients with presumed metabolic dysfunction-associated steatohepatitis, late-breaking data showed.
Top in endocrinology: Myths of ‘carb-phobia’; testosterone therapy has its limits
The recommendation that people living with diabetes should avoid carbohydrates is misguided, according to a speaker at the Lifestyle Medicine Conference.
‘Often overlooked’: Insulin resistance tops risk predictors for MASLD in lean patients
VANCOUVER, British Columbia — Insulin resistance, HbA1c and waist circumference represent independent risk factors for metabolic dysfunction-associated steatotic liver disease among lean patients, according to data presented here.
High mortality rates prove lean patients with NAFLD should ‘be taken seriously’
Lean patients with nonalcoholic fatty liver disease had significantly higher mortality than non-lean patients, despite having lower rates of cirrhosis and diabetes, according to research in Alimentary Pharmacology & Therapeutics.
Exposure to widespread synthetic pollutants linked to surprising ‘magnitude’ of HCC risk
Investigators have identified an elevated risk for hepatocellular carcinoma in people exposed to per- and polyfluoroalkyl substances, according to a study published in JHEP Reports.
Poor sleep increases odds for metabolic dysfunction-associated fatty liver disease
Adults who go to sleep later, snore and nap for more than 30 minutes during the day are more likely to develop metabolic dysfunction-associated fatty liver disease, according to study findings.
Low-carbohydrate, high-fat diet reduced fatty liver, improved type 2 diabetes control
LONDON — A low-carbohydrate, high-fat diet significantly improved nonalcoholic fatty liver disease activity score and HbA1c more than a high-carbohydrate, low-fat diet in people with type 2 diabetes mellitus, according to a researcher here.
HIV an independent risk factor for nonalcoholic steatohepatitis
A study of more than 1,300 women demonstrated that HIV is an independent risk factor for nonalcoholic steatohepatitis with significant nonalcoholic fatty liver disease activity and fibrosis, researchers reported.